61 related articles for article (PubMed ID: 15179553)
1. Inhaled IL-2 induces systemic immunomodulation in patients with renal cell carcinoma and lung metastasis.
Diaz D; Chara L; Chevarria J; Carballido J; Esteban E; Navas V; Monserrat J; Prieto A; de la Hera A; Alvarez-Mon M
Cancer Immunol Immunother; 2009 Feb; 58(2):235-45. PubMed ID: 18592236
[TBL] [Abstract][Full Text] [Related]
2. Induction of accessory cell function of human alveolar macrophages by inhalation of human natural interleukin-2.
Zissel G; Aulitzky WE; Lorenz J; Huber C; Müller-Quernheim J
Cancer Immunol Immunother; 1996 Feb; 42(2):122-6. PubMed ID: 8620521
[TBL] [Abstract][Full Text] [Related]
3. The Impact of a New Interleukin-2-Based Immunotherapy Candidate on Urothelial Cells to Support Use for Intravesical Drug Delivery.
Schmitz L; Berdien B; Huland E; Dase P; Beutel K; Fisch M; Engel O
Life (Basel); 2020 Oct; 10(10):. PubMed ID: 33027905
[TBL] [Abstract][Full Text] [Related]
4. Natural killer cell therapy and aerosol interleukin-2 for the treatment of osteosarcoma lung metastasis.
Guma SR; Lee DA; Yu L; Gordon N; Hughes D; Stewart J; Wang WL; Kleinerman ES
Pediatr Blood Cancer; 2014 Apr; 61(4):618-26. PubMed ID: 24136885
[TBL] [Abstract][Full Text] [Related]
5. Overview of interleukin-2 inhalation therapy.
Huland E; Heinzer H; Huland H; Yung R
Cancer J Sci Am; 2000 Feb; 6 Suppl 1():S104-12. PubMed ID: 10685669
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic approaches in metastatic renal cell carcinoma: local immunotherapy.
Huland E; Heinzer H; Jörres RA; Loppow D; Huland H
Urologe A; 2004 Sep; 43 Suppl 3():S140-4. PubMed ID: 15179553
[TBL] [Abstract][Full Text] [Related]
7. [Regional immunotherapy of metastatic renal cell carcinoma].
Heinzer H; Huland E; Huland H
Urologe A; 2002 May; 41(3):239-48. PubMed ID: 12132273
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of pulmonary metastases from kidney cell carcinoma with inhalational interleukin-2. 10-year experience Hamburger Unicenter].
Heinzer H; Huland E; Aalamian M; Huland H
Urologe A; 1999 Sep; 38(5):466-73. PubMed ID: 10501705
[TBL] [Abstract][Full Text] [Related]
9. A comparison of systemic versus inhaled recombinant IL-2 administration for the treatment of metastatic renal cell carcinoma.
Huland E; Heinzer H; Huland H
Folia Biol (Praha); 2000; 46(6):241-50. PubMed ID: 11140857
[TBL] [Abstract][Full Text] [Related]
10. [Inhaled immunotherapy for pulmonary metastases of renal cell cancer].
Lümmen G; Schenck M; Börgermann C; Eisenhardt A; Vom Dorp F; Sperling H; Rübben H
Urologe A; 2004 Apr; 43(4):457-61. PubMed ID: 15085267
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-2 inhalation therapy temporarily induces asthma-like airway inflammation.
Loppow D; Huland E; Heinzer H; Grönke L; Magnussen H; Holz O; Jörres RA
Eur J Med Res; 2007 Nov; 12(11):556-62. PubMed ID: 18024264
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of inhaled recombinant interleukin-2 in high-risk renal cell cancer patients compared with systemic interleukin-2: an outcome study.
Huland E; Burger A; Fleischer J; Fornara P; Hatzmann E; Heidenreich A; Heinzer H; Heynemann H; Hoffmann L; Hofmann R; Huland H; Kämpfer I; Kindler M; Kirchner H; Mehlhorn G; Moniak TH; Rebmann U; Roigas J; Schneider TH; Schnorr D; Schmitz HJ; Wenisch R; Varga Z; Vinke J
Folia Biol (Praha); 2003; 49(5):183-90. PubMed ID: 14680292
[TBL] [Abstract][Full Text] [Related]
13. Randomized study of high-dose and low-dose interleukin-2 in patients with metastatic renal cancer.
Yang JC; Sherry RM; Steinberg SM; Topalian SL; Schwartzentruber DJ; Hwu P; Seipp CA; Rogers-Freezer L; Morton KE; White DE; Liewehr DJ; Merino MJ; Rosenberg SA
J Clin Oncol; 2003 Aug; 21(16):3127-32. PubMed ID: 12915604
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
